schizoidman@lemmy.zip to World News@lemmy.worldEnglish · 5 days agoAstraZeneca to license lung cancer drug from China's Dizal Pharmaceuticalwww.reuters.comexternal-linkmessage-square4linkfedilinkarrow-up135arrow-down14 cross-posted to: world@quokk.auglobalnews@lemmy.zip
arrow-up131arrow-down1external-linkAstraZeneca to license lung cancer drug from China's Dizal Pharmaceuticalwww.reuters.comschizoidman@lemmy.zip to World News@lemmy.worldEnglish · 5 days agomessage-square4linkfedilink cross-posted to: world@quokk.auglobalnews@lemmy.zip
minus-squarefullsquare@awful.systemslinkfedilinkEnglisharrow-up2arrow-down1·edit-25 days agothere are drug trials that cost more money than that. also this is not +4 months comparison new drug vs nothing this is new drug vs old drug. if AZ also got their IP then it’s a fire sale here is study: https://ascopubs.org/doi/10.1200/JCO.2026.44.17_suppl.LBA8500
there are drug trials that cost more money than that. also this is not +4 months comparison new drug vs nothing this is new drug vs old drug. if AZ also got their IP then it’s a fire sale
here is study: https://ascopubs.org/doi/10.1200/JCO.2026.44.17_suppl.LBA8500